First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease-Reference-Cited by-同舟云学术

First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease

Published:2017-11-27 Issue:11 Volume:12 Page:e0188550
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ramírez Juan C.,Parrado Rudy,Sulleiro Elena,de la Barra Anabelle,Rodríguez Marcelo,Villarroel Sandro,Irazu Lucía,Alonso-Vega Cristina,Alves Fabiana,Curto María A.,García Lineth,Ortiz Lourdes,Torrico Faustino,Gascón Joaquim,Flevaud Laurence,Molina Israel,Ribeiro Isabela,Schijman Alejandro G.^ORCID

Funder

Wellcome Trust

Médecins Sans Frontières

Fondo para la Investigación Científica y Tecnológica

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. TDR/WHO. Research Priorities for Chagas Disease, Human African Trypanosomiasis and Leishmaniasis. WHO Technical Report Series. 2012; 975.

2. Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review;M-J Pinazo;Expert Rev Anti Infect Ther,2014

3. Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment;AI Porras;PLoS Negl Trop Dis,2015